The Basic Ordering Agreement (BOA) N0018924GZ016 was awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Rutgers, The State University. This single-award IDV has an ultimate completion date of August 15, 2034.
Under this BOA, Rutgers will provide a wide range of research and development services to the government across diverse fields such as biomedical sciences, engineering, computer science, environmental sciences, and social sciences. Key activities include operating the NIDA Center for Genetic Studies on behalf of the National Institute on Drug Abuse, which involves receiving, processing, storing, and distributing de-identified clinical data and biospecimens in support of addiction research. Rutgers has also received numerous prime and subcontract awards from agencies like the Department of Defense, NASA, and the Department of Health and Human Services to conduct cutting-edge research and deliver technical solutions. While most awards are made on a full and open basis, Rutgers has also secured some set-aside contracts designated for educational institutions. The university's extensive laboratory facilities, multidisciplinary expertise, and history of innovation position it well to address the government's research and development needs under this BOA.
Generated 12/13/24, 9:07 AM